首页 > 最新文献

Journal of the Formosan Medical Association最新文献

英文 中文
Analysis of possible factors affecting neurologic outcomes of resuscitated cardiac arrest patients with initial non-shockable rhythm after targeted temperature management.
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-02 DOI: 10.1016/j.jfma.2025.03.025
Herman Chih-Heng Chang, Min-Shan Tsai, Li-Kuo Kuo, Hsin-Hui Hsu, Wei-Chun Huang, Chih-Hung Lai, Chien-Hua Huang

Background: To identify the possible factors correlated with the outcomes of initial non-shockable rhythm cardiac arrest patients who received target temperature management (TTM).

Materials and methods: We utilized the Taiwan Network of Targeted Temperature ManagEment for CARDiac Arrest (TIMECARD) registry and selected patients with initial non-shockable rhythm as the study group from the registry. The primary outcome was a favorable neurologic outcome. Univariate and multivariate analyses were performed to identify significant variables.

Results: A total of 332 patients with initial non-shockable rhythm were selected. The factors significantly affecting neurologic outcome were pre-arrest CPC 1, in-hospital cardiac arrest event, an initial rhythm of PEA, received bystander cardiopulmonary resuscitation (CPR), a shorter CPR duration, a higher systolic blood pressure at return of spontaneous circulation (ROSC), a higher diastolic blood pressure (DBP) at ROSC, without new-onset seizure, experience of hypokalemia, and received percutaneous coronary intervention. The results of multivariate analysis revealed that patients with initial rhythm of PEA, higher DBP, without new-onset seizure, and experience of hypokalemia were associated with better neurologic outcome.

Conclusions: Initial non-shockable cardiac arrest patients who had initial rhythm of PEA, higher DBP at ROSC, hypokalemia but no new-onset seizure may be correlated to better neurologic outcome after TTM.

Trial registration:

Clinicaltrials: gov: NCT03578328.

{"title":"Analysis of possible factors affecting neurologic outcomes of resuscitated cardiac arrest patients with initial non-shockable rhythm after targeted temperature management.","authors":"Herman Chih-Heng Chang, Min-Shan Tsai, Li-Kuo Kuo, Hsin-Hui Hsu, Wei-Chun Huang, Chih-Hung Lai, Chien-Hua Huang","doi":"10.1016/j.jfma.2025.03.025","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.03.025","url":null,"abstract":"<p><strong>Background: </strong>To identify the possible factors correlated with the outcomes of initial non-shockable rhythm cardiac arrest patients who received target temperature management (TTM).</p><p><strong>Materials and methods: </strong>We utilized the Taiwan Network of Targeted Temperature ManagEment for CARDiac Arrest (TIMECARD) registry and selected patients with initial non-shockable rhythm as the study group from the registry. The primary outcome was a favorable neurologic outcome. Univariate and multivariate analyses were performed to identify significant variables.</p><p><strong>Results: </strong>A total of 332 patients with initial non-shockable rhythm were selected. The factors significantly affecting neurologic outcome were pre-arrest CPC 1, in-hospital cardiac arrest event, an initial rhythm of PEA, received bystander cardiopulmonary resuscitation (CPR), a shorter CPR duration, a higher systolic blood pressure at return of spontaneous circulation (ROSC), a higher diastolic blood pressure (DBP) at ROSC, without new-onset seizure, experience of hypokalemia, and received percutaneous coronary intervention. The results of multivariate analysis revealed that patients with initial rhythm of PEA, higher DBP, without new-onset seizure, and experience of hypokalemia were associated with better neurologic outcome.</p><p><strong>Conclusions: </strong>Initial non-shockable cardiac arrest patients who had initial rhythm of PEA, higher DBP at ROSC, hypokalemia but no new-onset seizure may be correlated to better neurologic outcome after TTM.</p><p><strong>Trial registration: </strong></p><p><strong>Clinicaltrials: </strong>gov: NCT03578328.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights.
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 Epub Date: 2025-03-14 DOI: 10.1016/j.jfma.2025.03.014
Jia-Horng Kao
{"title":"Highlights.","authors":"Jia-Horng Kao","doi":"10.1016/j.jfma.2025.03.014","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.03.014","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":"124 4","pages":"301-303"},"PeriodicalIF":2.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143753132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to comment to: Colchicine to prevent cardiovascular death after an acute myocardial infarction.
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.1016/j.jfma.2025.03.017
Ting-Tse Lin, Lung-Chun Lin
{"title":"Reply to comment to: Colchicine to prevent cardiovascular death after an acute myocardial infarction.","authors":"Ting-Tse Lin, Lung-Chun Lin","doi":"10.1016/j.jfma.2025.03.017","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.03.017","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143772628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver injury in non-severe COVID-19 with various pandemic phases: A real-world study.
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-31 DOI: 10.1016/j.jfma.2025.03.026
Jirayuth Winyupakorn, Chunlanee Sangketchon, Watcharaporn Devakul Na Ayutthaya, Supatsri Sethasine

Background: COVID-19 severity affects liver damage. The utilization of various anti-COVID-19 drugs in non-severe cases related to liver impairment in the short term seemed intriguing.

Objectives: To assess the dynamic course of liver injury in mild to moderate COVID-19 patients within 10 days of admission and identify risk variables, including medication linkage.

Methods: This prospective cohort study of 300 newly diagnosed mild to moderate COVID-19 cases between September 2021 and October 2022. Tertiary center hospitel, field hospital, or cohort ward admissions were made. Patient demographics and treatment were recorded. The drug, liver injury (LI) dynamics, and clinical course were evaluated.

Results: Hospitel/field hospital (188) and cohort wards (112) had 300 individuals. One hundred fifteen participants had liver damage. Favipiravir (45 %), remdesivir (17.4 %), molnupiravir (11.3 %), Andrographis paniculata (ADG) (8.7 %), and favipiravir plus ivermectin (7.7 %) were given to most LI group (n = 104). The baseline AST/ALT levels of 68 (65.4 %) treated patients were abnormal. Favipiravir, remdesivir, and favipiravir + ivermectin increased mean AST/ALT in participants with normal baseline AST/ALT (p = 0.001, 0.003, and 0.016, respectively), but not molnupiravir or Andrographis paniculata. Transaminase levels climbed in untreated patients independent of baseline. The ground-glass imaging pattern was linked to mild LI. Most subjects had transaminase declines after 10 days. Preexisting liver disease did not increase the likelihood of in-hospital LI.

Conclusion: In the real world, a less-than-critical level of liver damage was reported in mild to moderate COVID-19 that allows clinicians to administer a variety of standard medications during short periods of hospital stay.

{"title":"Liver injury in non-severe COVID-19 with various pandemic phases: A real-world study.","authors":"Jirayuth Winyupakorn, Chunlanee Sangketchon, Watcharaporn Devakul Na Ayutthaya, Supatsri Sethasine","doi":"10.1016/j.jfma.2025.03.026","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.03.026","url":null,"abstract":"<p><strong>Background: </strong>COVID-19 severity affects liver damage. The utilization of various anti-COVID-19 drugs in non-severe cases related to liver impairment in the short term seemed intriguing.</p><p><strong>Objectives: </strong>To assess the dynamic course of liver injury in mild to moderate COVID-19 patients within 10 days of admission and identify risk variables, including medication linkage.</p><p><strong>Methods: </strong>This prospective cohort study of 300 newly diagnosed mild to moderate COVID-19 cases between September 2021 and October 2022. Tertiary center hospitel, field hospital, or cohort ward admissions were made. Patient demographics and treatment were recorded. The drug, liver injury (LI) dynamics, and clinical course were evaluated.</p><p><strong>Results: </strong>Hospitel/field hospital (188) and cohort wards (112) had 300 individuals. One hundred fifteen participants had liver damage. Favipiravir (45 %), remdesivir (17.4 %), molnupiravir (11.3 %), Andrographis paniculata (ADG) (8.7 %), and favipiravir plus ivermectin (7.7 %) were given to most LI group (n = 104). The baseline AST/ALT levels of 68 (65.4 %) treated patients were abnormal. Favipiravir, remdesivir, and favipiravir + ivermectin increased mean AST/ALT in participants with normal baseline AST/ALT (p = 0.001, 0.003, and 0.016, respectively), but not molnupiravir or Andrographis paniculata. Transaminase levels climbed in untreated patients independent of baseline. The ground-glass imaging pattern was linked to mild LI. Most subjects had transaminase declines after 10 days. Preexisting liver disease did not increase the likelihood of in-hospital LI.</p><p><strong>Conclusion: </strong>In the real world, a less-than-critical level of liver damage was reported in mild to moderate COVID-19 that allows clinicians to administer a variety of standard medications during short periods of hospital stay.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143764264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 pandemic on the utilization of healthcare.
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-29 DOI: 10.1016/j.jfma.2025.03.020
Chung-Liang Shih, Oliver Liu, You-Jun Lin
{"title":"Impact of the COVID-19 pandemic on the utilization of healthcare.","authors":"Chung-Liang Shih, Oliver Liu, You-Jun Lin","doi":"10.1016/j.jfma.2025.03.020","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.03.020","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143752822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guide for Authors
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-29 DOI: 10.1016/S0929-6646(25)00129-9
{"title":"Guide for Authors","authors":"","doi":"10.1016/S0929-6646(25)00129-9","DOIUrl":"10.1016/S0929-6646(25)00129-9","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":"124 4","pages":"Pages e1-e8"},"PeriodicalIF":2.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copyright transfer statement
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-29 DOI: 10.1016/S0929-6646(25)00132-9
{"title":"Copyright transfer statement","authors":"","doi":"10.1016/S0929-6646(25)00132-9","DOIUrl":"10.1016/S0929-6646(25)00132-9","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":"124 4","pages":"Page e12"},"PeriodicalIF":2.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Checklist
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-29 DOI: 10.1016/S0929-6646(25)00130-5
{"title":"Checklist","authors":"","doi":"10.1016/S0929-6646(25)00130-5","DOIUrl":"10.1016/S0929-6646(25)00130-5","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":"124 4","pages":"Page e9"},"PeriodicalIF":2.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authorship statement
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-29 DOI: 10.1016/S0929-6646(25)00131-7
{"title":"Authorship statement","authors":"","doi":"10.1016/S0929-6646(25)00131-7","DOIUrl":"10.1016/S0929-6646(25)00131-7","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":"124 4","pages":"Pages e10-e11"},"PeriodicalIF":2.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and factors associated with informal advance care planning discussion and do-not-resuscitate directives in patients at geriatric clinics.
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-28 DOI: 10.1016/j.jfma.2025.03.024
Yu-Tai Lo, Sheng-Yu Fan, Chung-Yi Li, Deng-Chi Yang, Chi-Chang Huang, Mei-Hua Chen

Background: Advance care planning (ACP) discussions and do-not-resuscitate (DNR) directives are essential for ensuring quality end-of-life care, especially for older adults with multiple comorbidities. This study aimed to investigate the prevalence and associated factors of informal ACP discussions and DNR directives among geriatric outpatients in Taiwan.

Methods: A cross-sectional study was conducted among 276 Taiwanese geriatric outpatients aged 65 years and older. Data on demographics, comorbidities, functional status, informal ACP discussions, and DNR directives were collected. Multinomial logistic regression was used to analyze the association between independent variables and dependent variables (ACP discussion experience and DNR directives).

Results: While 92.1 % of participants reported having informal ACP discussions, only 8.3 % had completed DNR directives. Compared to those who only discussed ACP (reference group), individuals with a one-point higher Cumulative Illness Rating Scale for Geriatrics score were significantly more likely to have both discussed ACP and completed DNR directives (odds ratio [OR] = 1.14, 95 % confidence interval [CI]: 1.01-1.29, p = .035). Conversely, individuals with junior high school education or higher (OR = 0.25, 95 % CI: 0.08-0.84, p = .025) and those dependent on others for activities of daily living (ADL dependence; OR = 0.24, 95 % CI: 0.07-0.86, p = .029) were significantly less likely to have neither informally discussed ACP nor completed DNR directives.

Conclusion: While Taiwanese older outpatients often informally discussed ACP, the completion of DNR directives was less common. The link between higher geriatric comorbidity and DNR directives highlights the need for proactive, tailored interventions in this population.

{"title":"Prevalence and factors associated with informal advance care planning discussion and do-not-resuscitate directives in patients at geriatric clinics.","authors":"Yu-Tai Lo, Sheng-Yu Fan, Chung-Yi Li, Deng-Chi Yang, Chi-Chang Huang, Mei-Hua Chen","doi":"10.1016/j.jfma.2025.03.024","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.03.024","url":null,"abstract":"<p><strong>Background: </strong>Advance care planning (ACP) discussions and do-not-resuscitate (DNR) directives are essential for ensuring quality end-of-life care, especially for older adults with multiple comorbidities. This study aimed to investigate the prevalence and associated factors of informal ACP discussions and DNR directives among geriatric outpatients in Taiwan.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among 276 Taiwanese geriatric outpatients aged 65 years and older. Data on demographics, comorbidities, functional status, informal ACP discussions, and DNR directives were collected. Multinomial logistic regression was used to analyze the association between independent variables and dependent variables (ACP discussion experience and DNR directives).</p><p><strong>Results: </strong>While 92.1 % of participants reported having informal ACP discussions, only 8.3 % had completed DNR directives. Compared to those who only discussed ACP (reference group), individuals with a one-point higher Cumulative Illness Rating Scale for Geriatrics score were significantly more likely to have both discussed ACP and completed DNR directives (odds ratio [OR] = 1.14, 95 % confidence interval [CI]: 1.01-1.29, p = .035). Conversely, individuals with junior high school education or higher (OR = 0.25, 95 % CI: 0.08-0.84, p = .025) and those dependent on others for activities of daily living (ADL dependence; OR = 0.24, 95 % CI: 0.07-0.86, p = .029) were significantly less likely to have neither informally discussed ACP nor completed DNR directives.</p><p><strong>Conclusion: </strong>While Taiwanese older outpatients often informally discussed ACP, the completion of DNR directives was less common. The link between higher geriatric comorbidity and DNR directives highlights the need for proactive, tailored interventions in this population.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Formosan Medical Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1